title: Comorbidities in Psoriatic Arthritis.
abstract: Epidemiologic studies have shown that, in patients with psoriatic arthritis (PsA), associated comorbidities may occur more frequently than expected. This article discusses related comorbidities in patients with PsA. Identifying these comorbidities may affect the management and treatment decisions for these patients to ensure an optimal clinical outcome. All health care providers caring for patients with PsA should be aware of the relevant comorbidities and should have an understanding of how these comorbidities affect management. The common comorbidities include cardiovascular disease, metabolic syndrome, obesity, diabetes, fatty liver disease, inflammatory bowel disease, ophthalmic disease, kidney disease, osteoporosis, depression, and anxiety.
authors.affiliation: Department of Rheumatic and Immunologic Diseases, Clinical Outcomes Research, Arthritis and Musculoskeletal Center, Cleveland Clinic, Desk A50, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Electronic address: husnie@ccf.org.
authors.forename: M Elaine
authors.initials: ME
authors.lastname: Husni
mesh_terms: D015535:Arthritis, Psoriatic / Q000453:epidemiology*; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology*; D014943:Global Health; D006801:Humans; D024821:Metabolic Syndrome / Q000453:epidemiology*; D009765:Obesity / Q000453:epidemiology*; D012307:Risk Factors
keywords: Comorbidity; Management; Psoriasis; Psoriatic arthritis; Screening